PTPRC and neoplasm: Results show that tumour cells made up 61% of the bulk tumour; 31% of the cells within the bulk tumour were CD45− host cells (erythrocytes, tumour associated fibroblasts, endothelium and others); and the remaining 8% were CD45+ leukocytes (Fig. 5b).